All news (page 70)

• 

  29 October 2025

  Brenntag Specialties Pharma Partners with ArcticZymes for Exclusive Distribution of Salt-Active Nucleases

  The agreement enables wider access to salt-active nucleases for bioprocessing, enhancing product yield and reducing costs in gene therapy and vaccine production.
• 

  29 October 2025

  UPM Q3 2025: Resilient Performance Amid Weak Markets

  Sales and EBIT declined. Strategic reviews and partnerships initiated. Plywood and paper production adjustments. Biorefinery progress. Sustainability recognized. Uncertainty persists.
• 

  29 October 2025

  Equinor Q3 2025 Financial Results

  Adjusted operating income at $6.21B. Production up 7%. Strong cash flow, cost focus, and strategic developments. Dividend set at $0.37/share.
• 

  29 October 2025

  OMV Boosts Q3 2025 Clean CCS Operating Result by 20% to EUR 1.3 Billion

  Fuels and Chemicals drive growth; Energy segment declines. Cash flow up 7%, leverage at 16%. Progress on Borouge Group and Neptun Deep project.
• 

  29 October 2025

  Neste Q3 2025 Interim Report

  Improved Q3 results driven by performance actions and market recovery. Renewable and oil product sales rose, but cash flow was negative. Strategic growth in Rotterdam continues.
• 

  29 October 2025

  BASF Q3 2025 Earnings Slightly Exceed Market Expectations

  Sales fell 3% due to currency effects and lower prices. EBITDA before special items was €1.5 billion. Share buyback program to start in November 2025.

• 

  29 October 2025

  Sumitomo Corporation Secures Financing for Uzbekistan's Largest Solar and Battery Project

  The project will generate 1,000 MW of solar power and 1,336 MWh of storage, supporting Uzbekistan's energy transition with a 25-year power purchase agreement. Completion is expected post-2027.
• 

  29 October 2025

  Ørsted and Worley Sign Long-Term EPCM Agreement

  The eight-year deal supports power generation and CCS in Denmark, enhancing energy infrastructure and decarbonization efforts with a focus on safety and sustainability.
• 

  28 October 2025

  Novo Nordisk to Present Wegovy® Data at 2025 AASLD Meeting

  11 abstracts on Wegovy® and MASH to be presented at AASLD 2025, highlighting clinical and real-world data, including post-hoc analyses of the ESSENCE trial.
• 

  28 October 2025

  NEXTCHEM Unveils Sustainability-Linked Financing Framework

  The Framework sets targets for supplier engagement and avoided emissions, supporting sustainable financing and aligning with decarbonization goals.
• 

  28 October 2025

  Uniper Launches Green Finance Framework for Energy Transition

  The framework aligns with EU Taxonomy, supports projects like wind, solar, and hydrogen, and follows Green Bond and Loan Principles. S&P Global Ratings confirms compliance.
• 

  28 October 2025

  LOTTE Chemical Launches Heat-Resistant Adhesive for Food Packaging

  The adhesive enhances moisture and oxygen barriers, maintains adhesion at high temperatures, and is now used in instant rice containers, with plans for broader food packaging applications.
• 

  28 October 2025

  PPG Q3 2025 Financial Results

  Net sales rose 1% to $4.1B. Organic sales up 2%. Record EPS of $1.96, adjusted EPS $2.13. Segment margin 17%, EBITDA margin 20%. $150M in share repurchases this quarter.
• 

  28 October 2025

  LyondellBasell Names Polysaf Ltd. Distributor in Israel

  Polysaf Ltd. will handle customer interactions in Israel for LYB's non-medical products, enhancing service and support.
• 

  28 October 2025

  Aramco and GIP Finalize $11 Billion Jafurah Midstream Deal

  The Jafurah project will start production by year-end, expanding gas capacity and supporting Saudi Arabia's growth in energy and petrochemicals.
• 

  28 October 2025

  Merck's KEYTRUDA and WELIREG Combo Improves DFS in RCC Patients Post-Nephrectomy

  The LITESPARK-022 trial shows improved DFS with KEYTRUDA and WELIREG in RCC patients. Safety profiles align with previous studies. Results to be shared with regulators.
• 

  28 October 2025

  Merck and Eisai's WELIREG and LENVIMA Improve PFS in Advanced Renal Cell Carcinoma Trial

  The trial showed significant PFS and ORR improvements with WELIREG and LENVIMA in advanced RCC patients post anti-PD-1/L1 therapy, with consistent safety profiles.
• 

  28 October 2025

  European Commission Launches Critical Chemicals Alliance

  The Alliance aims to boost EU chemical industry by identifying critical molecules, enhancing trade monitoring, and supporting investments. Open to industry stakeholders for collaboration.
• 

  28 October 2025

  Port of Rotterdam Throughput Declines 2.6% in Q3 2025

  Throughput fell due to lower iron ore and mineral oil volumes. Container and renewable fuel throughput rose, highlighting the port's resilience amid European industry challenges.
• 

  28 October 2025

  BASF Announces Executive Board Changes

  Mary Kurian and Livio Tedeschi join BASF's Board in 2026. Michael Heinz to retire. New responsibilities assigned across segments.
• 

  28 October 2025

  Topsoe's SOEC Technology Chosen for Forestal's E-Methanol Project

  Topsoe's SOEC tech will power Forestal's Triskelion e-methanol project in Spain, enhancing efficiency and sustainability, with operations set for 2028.
• 

  28 October 2025

  ORLEN Secures PLN 3.5 Billion for Offshore Wind Projects

  Funds from the National Recovery Plan will support offshore wind projects, enhancing Poland's energy security and economic growth, with Baltic Power and Baltic East as key initiatives.
• 

  28 October 2025

  TotalEnergies, Aljomaih Secure 400 MW Solar Project in Saudi Arabia

  The 400 MW solar plant in As Sufun will power 68,400 homes by 2027, supporting Saudi Vision 2030's renewable energy goals.
• 

  28 October 2025

  Evonik Enhances Antwerp Logistics for MetAMINO®

  New filling and storage upgrades boost packaging flexibility, safety, and supply security for MetAMINO®, meeting rising demand for larger units and reducing CO2 footprint of 25kg bags.
• 

  28 October 2025

  Roche's Gazyva Shows Positive Phase III Results in Pediatric Nephrotic Syndrome

  Gazyva achieved sustained remission in young nephrotic syndrome patients, reducing steroid use. No new safety issues. Data to be shared with health authorities.
• 

  28 October 2025

  NEXTCHEM Launches Sustainability-Linked Financing Framework

  The Framework sets targets for supplier engagement and avoided emissions, supporting sustainable financing and aligning with international principles.
• 

  28 October 2025

  Air Liquide Q3 2025: Sales Growth and Strategic Successes

  Revenue rose 1.9% on a comparable basis. Healthcare and Industrial Merchant drove growth. Investment momentum strong with major projects. DIG Airgas acquisition in South Korea planned.
• 

  28 October 2025

  Symrise Q3 2025 Sales Report

  Symrise reports 1.4% organic growth in Q3 2025. Adjusts annual growth outlook to 2.3%-3.3% due to market challenges. Continues ONE SYM Transformation and cost-saving initiatives.
• 

  28 October 2025

  Worley Restructures Executive Team for AI Transformation

  Worley reduces its executive team to nine, appoints Laura Leonard as Chief AI Officer to drive AI transformation, enhancing agility and innovation.
• 

  27 October 2025

  Rompetrol Rafinare Advances Storage Capacity Investment

  Rompetrol Rafinare upgrades tank farms, boosting storage by 20% and enhancing safety and efficiency at Petromidia refinery.